Please login to the form below

Not currently logged in
Email:
Password:

Contract research organisation PRA opens Singapore office

Continues its Asia-Pacific expansion with new centralised operations base

PRA has opened a new office in Singapore that will act as a centralised operations base for its activities in the region.

The US contract research organisation's new facility will provide monitoring, project management, safety reporting, feasibility and other services.

Helen Neal, PRA's director of clinical operations for Asia-Pacific, said: "Building our capability across the region with the centre in Singapore permits our sponsors to experience a wider range of services and expertise.

"This location provides our teams with access to experts and resources within their time zone, positively impacting our speed and quality of delivery on projects."

PRA has been steadily expanding its Asia-Pacific operations since 2000 and its operations in the region also include Korea, Taiwan, China, Hong Kong, Thailand, Australia, New Zealand, and India.

The expansion mirrors investments from the pharma industry in new research operations. Last year Merck & Co pledged $1.5bn to expand its presence in China and Bayer said it expects Asia to account for €11bn of sales by 2015.

24th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Leveraging HCP Transparency Insights to Drive Future Customer Investments
EFPIA’s disclosure requirements present an opportunity to assess strategy and effectiveness...
How did pharma use Twitter at #ASCO16?
Each year, ASCO’s Annual Meeting brings together 30,000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how pharma utilised the channel during this year's event....
WHITE PAPER: How to engage with HCPs more effectively
Shrinking budgets and limitations on the time HCPs can spend with sales reps is making traditional engagement methods more and more ineffective. So, in order to reach the unreachable, pharma...

Infographics